Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, according to the agent’s manufacturer. Cemiplimab (Libtayo, Regeneron Pharmaceutica ...

Allergy and immunology lost a pioneer last summer with the death of Marcus Maurer, MD, executive director of the Institute of Allergology at Charité University Medicine, Berlin. Maurer was an author ...

Time-restricted eating, particularly among people with underlying metabolic disorders, may confer benefits beyond weight loss ...

In this video from , Michael J. Stuart, MD, emeritus professor and orthopedic surgeon at Mayo Clinic Rochester, discussed the importance of meniscus preservation.“One of my favorite techniques is ...

In this video from , Pamela J. Lund, MD, national director of MSK imaging at SimonMed Imaging, highlights a session on the management of knee disorders in 2025.“We had a great knee session today that ...

In this video from , Adam B. Yanke, MD, PhD, spoke about augmenting ACL reconstruction with lateral extra-articular tenodesis using an iliotibial band graft to improve stability.Yanke, associate ...

Maintaining healthful behaviors may be key to improving the trajectory of heart health from early adolescence into adulthood, according to study findings published in JAMA Cardiology.To identify the ...

In this video, Aaron J. Krych, MD, highlights key discussions held during a session on meniscus tears and treatment at Orthopedics Today Hawaii.“We had great discussions from world-class orthopedic ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Registered dietitian nutritionists caring for patients with chronic kidney disease are frequently challenged to help address ...

This month’s Healio Exclusive highlights an essential dialogue on gender disparities in medicine, particularly in ...

A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit, Biofrontera ...